Current position of 5HT3 antagonists and the additional value of NK1, antagonists; a new class of antiemetics

Research output: Contribution to journalArticleAcademicpeer-review

32 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1823-1827
Number of pages5
JournalBritish Journal of Cancer
Volume88
DOIs
Publication statusPublished - 2003

Cite this